The epidermal growth factor receptor as a target for cancer therapy.

John Mendelsohn(Unknown)
Endocrine Related Cancer
March 1, 2001
10.1677/erc.0.0080003
Cited by 331

Related Papers

Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With Cisplatin
|Journal of Clinical Oncology|2000|746
True
|British Journal of Cancer|2000|127
Understanding continent-wide variation in vulture ranging behavior to assess feasibility of Vulture Safe Zones in Africa: Challenges and possibilities
|Biological Conservation|2022|23